JUL 10, 2018 11:15 PM PDT

TdT Positive Cells - Not Just for Neoplasms

WRITTEN BY: Mauri Brueggeman
2 1 71

Terminal deoxyncleotidyl transferase (TdT) is a unique DNA polymerase molecule that is expressed by immature lymphoid cells, both normal and mutagenic.  As a cell ages, it loses the TdT expression capability.  Young lymph progenitor cells would be expected then to have this cell marker; cancerous lymph cells can be mutated versions of those young lymph progenitor cells growing out of control so increased TdT levels could be expected, and in fact have been used diagnostically in laboratory medicine.  TdT has been an identifiable marker since the late 1980s where it was found to be enhanced in acute undifferentiated leukemias, immature acute lymphoblastic leukemias, and in a fraction of cases of leukemic patients in blast crisis.  TdT acts by catalyzing the reaction that leads to the addition of deoxynucleotides to hydroxyl ends of oligonucleotides as part of DNA synthesis.  It also contributes to differences in antibody recognition sites by rearrangement of immunoglobulins or T-cell receptors.  It has long been associated with very undifferentiated neoplasms.

A new article published in the journal Human Pathology is a reminder that healthy lymph nodes and lymph cells can also express TdT because they are early lymphoid precursors; this is especially true in pediatric lymph nodes.  There are benign TdT positive lymph nodes in pediatric patients and this group focused on characterizing the presence of benign TdT positive cells and characterize the typical phenotype associated with their presence. 

Findings included that TdT was sparsely positive in all pediatric cases and in more than three quarters of adult lymph nodes evaluated (n=141).  It was noted that there was increased density of TdT positive cells in pediatric lymph nodes and TdT presence was not found to be associated with any clinical or histological factor other than identifying that these were lymphoid precursors with CD34 and CD10 also being expressed.

The study serves as a reminder to be mindful of the common phenotype of TdT positivity in early healthy lymphoid precursors and to carefully avoid misidentification of these cells as early neoplasm markers.

Sources: Human Pathology, International Journal of Biological Markers, American Journal of Clinical Pathology, Pathology Outlines,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
APR 06, 2018
Cancer
APR 06, 2018
PanCancer Atlas of 33 Cancer Types for Genomic Profile Index Completed by NIH TCGA
The Cancer Genome Atlas project used genomic profiles and bioinformatics to catalogue 33 prevalent types of cancer and is available to the public after 10+ years of analysis.
MAY 14, 2018
Cancer
MAY 14, 2018
What Is Computational Oncology?
Computational Oncology is an emerging field of science and medicine aimed at using mathematical and computer modeling systems to organize tumor marker profiles and hone precision medicine.
MAY 29, 2018
Genetics & Genomics
MAY 29, 2018
A Pair of Genomes is Best
Researchers have now learned more about why cells that have improper numbers of chromosomes, which will help cancer research.
JUN 12, 2018
Cancer
JUN 12, 2018
CD44 Insights & Cancer Influence
CD44 is a known cell surface protein involved in numerous interactions; it is overexpressed in cancerous tissue and its isoforms are being investigated as targets for cancer immunotherapy
JUN 27, 2018
Immunology
JUN 27, 2018
Immune Cells Responsible for Chemo-induced Diarrhea
While studying specific immune cells in the context of chronic itching in the skin, two Washington University School of Medicine scientists discovered that
JUL 03, 2018
Cancer
JUL 03, 2018
Hereditary Myeloid Neoplasm Predisposition
New changes in myeloid classification help to outline a new category of AML which develops as a result of hereditary mutations predisposing family members to myeloid neoplasms in adulthood.
Loading Comments...